probenecid has been researched along with Hemorrhagic Proctocolitis in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rompalo, AM | 1 |
| Roberts, P | 1 |
| Johnson, K | 1 |
| Stamm, WE | 1 |
1 trial available for probenecid and Hemorrhagic Proctocolitis
| Article | Year |
|---|---|
Empirical therapy for the management of acute proctitis in homosexual men.
Topics: Adolescent; Adult; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Drug Therapy, Combinati | 1988 |